Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

March 15, 2006 updated by: University Hospital, Geneva
To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
    • Geneva
      • Collonge-Bellerive (Geneva), Geneva, Switzerland, 1245
        • Center of Continuous Care, chemin de la Savonnière

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Cancer patients in palliative care
  • Patients fully informed about their condition
  • Signed informed consent
  • No exclusion criteria

Exclusion Criteria:

  • Absence of advanced cancer
  • Cancer previously cured
  • Venous thromboembolism diagnosed within 6 months prior to inclusion
  • Absence of discerning capacity
  • Active anti-thrombotic treatment with heparins or coumarines
  • Thrombocytopenia <50G/l
  • PTT >45sec
  • TP<35%
  • Active bleeding
  • Renal failure <20ml/min
  • Past history of heparin-induced thrombocytopenia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Geneva

Investigators

  • Principal Investigator: Catherine Weber, MD, Center of Continuous Care, chemin de la Savonnière 11, CH-1245 Collonge-Bellerive

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2001

Study Completion

July 1, 2002

Study Registration Dates

First Submitted

March 15, 2006

First Submitted That Met QC Criteria

March 15, 2006

First Posted (Estimate)

March 16, 2006

Study Record Updates

Last Update Posted (Estimate)

March 16, 2006

Last Update Submitted That Met QC Criteria

March 15, 2006

Last Verified

December 1, 2005

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SPOT 99/54

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe